When a postsynaptic neuron becomes active, it produces endocannabinoids on demand rather than storing them for routine release. These lipid messengers travel backward across the synapse and act on presynaptic cannabinoid receptors, reducing neurotransmitter release. This direction of communication allows the receiving neuron to influence the strength of incoming signals and helps regulate neural activity.
Endocannabinoid signaling depends on enzymes that synthesize the ligands and enzymes that degrade them. Synthesis makes molecules such as anandamide and 2-arachidonoylglycerol available when neuronal activity requires them, whereas degradation removes those signals afterward. Together, these pathways help constrain the timing and persistence of receptor activation rather than leaving synaptic effects uncontrolled.
The system operates through coordinated roles: endogenous ligands carry the signal, cannabinoid receptors detect it, and metabolic enzymes regulate ligand availability. CB1 and CB2 are the principal receptor types identified in the overview, while anandamide and 2-arachidonoylglycerol are key endogenous ligands. Examining all three components gives researchers a fuller view of how signaling is initiated and terminated.
Research connects this signaling network with pain, mood, memory, appetite, and stress responses. These functions span sensory processing, emotional and cognitive states, feeding-related regulation, and adaptation to stress. Studying the system across these processes helps neuroscience researchers examine how a shared signaling framework can influence different physiological outcomes without reducing its relevance to only one behavior.
A useful investigation considers receptor types, endogenous ligands, and the enzymes responsible for their synthesis and degradation. Researchers can then relate these components to retrograde effects on presynaptic neurotransmitter release and to broader functions such as pain, memory, or stress responses. This component-based approach connects molecular signaling with neural communication and physiological regulation.
The system provides several research targets because its receptors and metabolic pathways can be examined separately or together. Investigators study these targets to improve understanding of neurological disease and to explore potential therapies. Findings may also clarify how altered signaling relates to functions such as mood, pain, memory, appetite, and stress, while distinguishing receptor effects from metabolic regulation.